Clinical Trials Directory

Trials / Completed

CompletedNCT01916473

Epidural Versus Continuous Wound Ropivacaine Infusion Analgesia

Epidural Versus Continuous Wound Ropivacaine Infusion: Effect on Acute and Chronic Pain After Myomectomy or Total Abdominal Hysterectomy. A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
University of Athens · Academic / Other
Sex
Female
Age
25 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Study Hypothesis: The analgesic requirements and pain scores postoperatively differ between the epidural and continuous wound infusion techniques.

Detailed description

The analgesic requirements and pain scores postoperatively differ between the epidural and continuous wound infusion techniques, in patients undergoing myomectomy or hysterectomy.

Conditions

Interventions

TypeNameDescription
OTHEREpidural analgesiaEpidural analgesia is provided with ropvacaine 0.2% given 6 hourly
OTHERContinuous wound infusionContinuous wound infusion via catheter

Timeline

Start date
2010-04-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2013-08-05
Last updated
2013-08-05

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01916473. Inclusion in this directory is not an endorsement.

Epidural Versus Continuous Wound Ropivacaine Infusion Analgesia (NCT01916473) · Clinical Trials Directory